cIAP proteins: keystones in NOD receptor signal transduction

Colin Reardon1, Tak W Mak

  • 1Campbell Family Cancer Research Institute, Princess Margaret Hospital, Toronto, ON, Canada. creardon@uhnres.utoronto.ca

Immunity
|June 23, 2009
PubMed

Insights

NOD1 and 2 are key to innate immunity. New research shows cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2) act as E3 ubiquitin ligases for RIP2, clarifying the NOD signaling pathway.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Signaling

Background:

  • Nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are intracellular pattern recognition receptors crucial for innate immunity.
  • NOD1 and NOD2 activation initiates signaling cascades that lead to inflammatory responses.
  • The precise molecular mechanisms linking NOD receptor activation to downstream signaling, particularly the role of RIP2 ubiquitination, remain incompletely understood.

Purpose of the Study:

  • To elucidate the function of cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2) in the NOD signaling pathway.
  • To identify the role of cIAP1/2 as E3 ubiquitin ligases for the RIP2 signaling molecule.
  • To further delineate the molecular events governing innate immune responses initiated by NOD receptors.

Main Methods:

  • Co-immunoprecipitation assays to assess protein-protein interactions.
  • In vitro ubiquitination assays to determine E3 ligase activity.
  • Western blotting to detect ubiquitination of RIP2.
  • Analysis of NOD signaling pathway activation in response to stimulation.

Main Results:

  • Bertrand et al. demonstrate that cIAP1 and cIAP2 directly interact with RIP2.
  • cIAP1 and cIAP2 function as E3 ubiquitin ligases, catalyzing the ubiquitination of RIP2.
  • This ubiquitination is a critical step in the NOD signaling cascade, influencing downstream immune activation.

Conclusions:

  • The study identifies cIAP1 and cIAP2 as key components of the NOD signaling pathway.
  • The findings reveal that cIAP1/2-mediated ubiquitination of RIP2 is essential for proper innate immune signaling.
  • This work fills a significant gap in understanding the molecular regulation of NOD-initiated immune responses.

Related Concept Videos

Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...